FDA Biologics (BLA & Biosimilars)Original article
Development and Licensure of Vaccines to Prevent COVID-19
RegulatoryCOVID-19 vaccinesNeutral
AI Analysis
Summary
FDA's Center for Biologics Evaluation and Research (CBER) has issued guidance for industry on the development and licensure of COVID-19 vaccines. This is a regulatory document providing procedural and technical requirements for vaccine manufacturers.
Importance:2/10
Sentiment:
0.00
FDA guidancevaccine developmentCOVID-19CBERlicensure
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on August 3, 2026 7:21 PM